Status:
ACTIVE_NOT_RECRUITING
Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Alcohol-related Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A sample of 30 alcohol-related liver disease patients will be recruited through consecutive sampling, facilitated through the Alcohol Care Team, which will identify potential participants to the study...
Detailed Description
A sample of 30 ARLD patients will be recruited through consecutive sampling, facilitated through the ACT, who will identify potential participants to the study that have been referred to the team. The...
Eligibility Criteria
Inclusion
- 18 years old or above.
- Able to communicate in English independently.
- Formal diagnosis of ARLD in line with ICD-10 K70 codes (fatty liver, hepatitis, fibrosis, sclerosis, cirrhosis, hepatic failure, unspecified liver disease) upon discharge following acute liver disease episode.
- Formal diagnosis of AD in line with ICD-10 F10.2 codes.
- Attending South London liver services (King's Health Partners).
- Able and willing to provide informed consent.
- Able and willing to participate in study.
- Owning a mobile phone.
Exclusion
- Less than 18 years old.
- Current dependence on other substances other than alcohol, tobacco, or cannabis.
- Inability to communicate in English independently.
- Being pregnant.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06183710
Start Date
January 1 2023
End Date
September 30 2024
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital
London, United Kingdom, SE5 8AF